首页 > 最新文献

Rinsho byori. The Japanese journal of clinical pathology最新文献

英文 中文
[Notes on the Features of an Outbreak Caused by MDRA in Our Hospital]. 【关于我院一起MDRA疫情特点的说明】。
Terumi Kinoshita, Kiyohito Ishikawa

In Japan, the criteria for multi-drug-resistant Acinetobacter baumannii (MDRA) have been developed in response to two large-scale MDRA outbreaks reported in 2010. A. baumannii can survive for a long period in a dry environment, and it is also detected frequently from carriers over a long period. For mixed infection with some other bacteria, it cannot be accurately detected due to masking by other bacteria. For these reasons, the detection of MDRP infection is delayed. Furthermore, the infection control of MDRA must require the determination of the quarantine period, release criteria, and a clean environment, without sufficient levels of evidence. It is not rare for this to take more than a year to resolve an MDRA outbreak. Therefore, it is important to monitor daily occurrence in any hospital. [Review].

在日本,针对2010年报告的两次大规模耐多药鲍曼不动杆菌暴发,制定了耐多药鲍曼不动杆菌(MDRA)的标准。鲍曼不动杆菌可以在干燥的环境中存活很长一段时间,并且在很长一段时间内也经常从携带者身上检测到。对于与其他一些细菌混合感染,由于被其他细菌掩盖,无法准确检测。由于这些原因,MDRP感染的检测被推迟。此外,在没有足够证据的情况下,MDRA的感染控制必须要求确定隔离期、释放标准和清洁环境。解决MDRA爆发需要一年多的时间并不罕见。因此,监测任何医院的日常发生情况都是很重要的。(审查)。
{"title":"[Notes on the Features of an Outbreak Caused by MDRA in Our Hospital].","authors":"Terumi Kinoshita,&nbsp;Kiyohito Ishikawa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In Japan, the criteria for multi-drug-resistant Acinetobacter baumannii (MDRA) have been developed in response to two large-scale MDRA outbreaks reported in 2010. A. baumannii can survive for a long period in a dry environment, and it is also detected frequently from carriers over a long period. For mixed infection with some other bacteria, it cannot be accurately detected due to masking by other bacteria. For these reasons, the detection of MDRP infection is delayed. Furthermore, the infection control of MDRA must require the determination of the quarantine period, release criteria, and a clean environment, without sufficient levels of evidence. It is not rare for this to take more than a year to resolve an MDRA outbreak. Therefore, it is important to monitor daily occurrence in any hospital. [Review].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 11","pages":"1271-1278"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36909253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[How Long Are Unstained Sections Available for Immunostaining? -A Study of Antigenicity Preservation Time-]. [未染色切片可用于免疫染色多长时间?-抗原性保存时间的研究[j]。
Shinichi Inoue, Yoshinori Matsuki, Masaya Mori

It is well known that the antigenicity of unstained sections put on a slide glass decreases when the slides are stored at room temperature. Several methods have been reported to prevent reduced antigenicity, such as storing in a dark place at 4°C, covering sections with paraffin or a sheet, and storing in a deep freezer at -80°C. The aim of the present study is to determine how long unstained sections can be stored in a refriger- ator (ie, 1 week, 2 weeks, 1 month and 2 months). Each section was well stained and equal to the day 0 section for CD3, CD20, bcl-2, bcl-6, ER, PgR, HER2, Ki-67, chromogranin-A, synaptophysin, CK5, CK7, CK20, and TTF-1. In conclusion, unstained sections can be used for immunostaining after at least 2 months of storage, and preparing several control sections and storing them in a refrigerator is useful for minimizing control block loss. [Original].

众所周知,当载玻片在室温下保存时,未染色的切片放在载玻片上的抗原性降低。据报道,有几种方法可以防止抗原性降低,例如在4°C的黑暗处保存,用石蜡或薄片覆盖切片,并在-80°C的深度冰箱中保存。本研究的目的是确定未染色切片可以在冰箱中保存多长时间(即1周,2周,1个月和2个月)。每个切片染色良好,与第0天切片相同,表达CD3、CD20、bcl-2、bcl-6、ER、PgR、HER2、Ki-67、嗜铬粒蛋白a、突触素、CK5、CK7、CK20和TTF-1。总之,保存至少2个月后,未染色的切片可用于免疫染色,制备几个对照切片并将其保存在冰箱中有助于减少对照块的损失。(最初的)。
{"title":"[How Long Are Unstained Sections Available for Immunostaining? -A Study of Antigenicity Preservation Time-].","authors":"Shinichi Inoue,&nbsp;Yoshinori Matsuki,&nbsp;Masaya Mori","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>It is well known that the antigenicity of unstained sections put on a slide glass decreases when the slides are stored at room temperature. Several methods have been reported to prevent reduced antigenicity, such as storing in a dark place at 4°C, covering sections with paraffin or a sheet, and storing in a deep freezer at -80°C. The aim of the present study is to determine how long unstained sections can be stored in a refriger- ator (ie, 1 week, 2 weeks, 1 month and 2 months). Each section was well stained and equal to the day 0 section for CD3, CD20, bcl-2, bcl-6, ER, PgR, HER2, Ki-67, chromogranin-A, synaptophysin, CK5, CK7, CK20, and TTF-1. In conclusion, unstained sections can be used for immunostaining after at least 2 months of storage, and preparing several control sections and storing them in a refrigerator is useful for minimizing control block loss. [Original].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 11","pages":"1215-1219"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36953151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[IgM-Lambda Type Paraproteinemia Interferes with Haptoglobin Measurements]. [IgM-Lambda型副蛋白血症干扰珠蛋白测量]。
Takahiro Nojiri, Akiko Masuda, Ryunosuke Ohkawa, Shigeo Okubo, Makoto Kurano, Hitoshi Ikeda, Yutaka Yatomi

Paraproteinemia is a condition induced by an increase in paraprotein. Paraprotein is a monoclonal immu- noglobulin produced by plasma cells as a result of aging or malignancy. Paraprotein often induces a variety of laboratory test abnormalities by interfering with laboratory test reagents. The haptoglobin (Hp) measurement in a 55-year-old woman with IgM-lambda type paraproteinemia associated with lymphoplasmacytic lymphoma was found to be falsely low because of white-turbidity caused by an abnormal reaction. An in- creased absorbance was observed at 596 nm after the addition of the buffer reagent and was reduced by dilution with saline. This result indicates the existence of interfering substances in the patient's sample. To identify the inhibitors, we obtained the white-turbidity pellet by centrifugation of a mixture of the patient's serum and the Hp buffer reagent. A high IgM concentration was observed in the white-turbidity pellet. Moreover, a correlation was observed in a time series between the IgM concentration in sera and the extent of the turbidity during the Hp measurement. These results indicated that IgM was the main component of the white-turbidity. Next, we showed that the addition of the white-turbidity pellet to normal serum caused an increase in absorbance and a false low Hp value. A correlation was also observed in a time series be- tween the IgM concentration in sera and the rate of the Hp reduction. These results suggest that the false low Hp measurements were due to IgM present in the white-turbidity. In conclusion, false low values of Hp may occur in patients with IgM-lambda type paraproteinemia. Therefore, the presence or absence of an increase in absorbance after the addition of the buffer reagent in a time-course reaction may be required.

副蛋白血症是由副蛋白增加引起的一种疾病。副蛋白是浆细胞由于衰老或恶性肿瘤而产生的一种单克隆免疫球蛋白。副蛋白常通过干扰实验室检测试剂而诱发多种实验室检测异常。55岁女性IgM-lambda型副蛋白血症伴淋巴浆细胞性淋巴瘤患者,由于异常反应引起白色浑浊,其接触珠蛋白(Hp)检测结果被误认为低。加入缓冲试剂后,在596 nm处观察到吸光度增加,用生理盐水稀释后吸光度降低。这一结果表明患者的样品中存在干扰物质。为了鉴定抑制剂,我们通过将患者血清和Hp缓冲试剂的混合物离心获得白色浊度颗粒。白浊颗粒中IgM浓度较高。此外,在时间序列中观察到血清中IgM浓度与Hp测量期间浊度的程度之间存在相关性。这些结果表明IgM是白色浊度的主要成分。接下来,我们发现将白浊颗粒添加到正常血清中会导致吸光度增加和假的低Hp值。在时间序列中也观察到血清中IgM浓度与Hp降低率之间的相关性。这些结果表明,假的低Hp测量是由于IgM存在于白色浊度。总之,IgM-lambda型副蛋白血症患者可能出现假低Hp值。因此,在一个时间过程的反应中,加入缓冲试剂后的吸光度是否增加可能是必需的。
{"title":"[IgM-Lambda Type Paraproteinemia Interferes with Haptoglobin Measurements].","authors":"Takahiro Nojiri,&nbsp;Akiko Masuda,&nbsp;Ryunosuke Ohkawa,&nbsp;Shigeo Okubo,&nbsp;Makoto Kurano,&nbsp;Hitoshi Ikeda,&nbsp;Yutaka Yatomi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Paraproteinemia is a condition induced by an increase in paraprotein. Paraprotein is a monoclonal immu- noglobulin produced by plasma cells as a result of aging or malignancy. Paraprotein often induces a variety of laboratory test abnormalities by interfering with laboratory test reagents. The haptoglobin (Hp) measurement in a 55-year-old woman with IgM-lambda type paraproteinemia associated with lymphoplasmacytic lymphoma was found to be falsely low because of white-turbidity caused by an abnormal reaction. An in- creased absorbance was observed at 596 nm after the addition of the buffer reagent and was reduced by dilution with saline. This result indicates the existence of interfering substances in the patient's sample. To identify the inhibitors, we obtained the white-turbidity pellet by centrifugation of a mixture of the patient's serum and the Hp buffer reagent. A high IgM concentration was observed in the white-turbidity pellet. Moreover, a correlation was observed in a time series between the IgM concentration in sera and the extent of the turbidity during the Hp measurement. These results indicated that IgM was the main component of the white-turbidity. Next, we showed that the addition of the white-turbidity pellet to normal serum caused an increase in absorbance and a false low Hp value. A correlation was also observed in a time series be- tween the IgM concentration in sera and the rate of the Hp reduction. These results suggest that the false low Hp measurements were due to IgM present in the white-turbidity. In conclusion, false low values of Hp may occur in patients with IgM-lambda type paraproteinemia. Therefore, the presence or absence of an increase in absorbance after the addition of the buffer reagent in a time-course reaction may be required.</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 11","pages":"1236-1242"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36953154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vancomycin-Resistant Enterococci]. [Vancomycin-Resistant Enterococci]。
Shunji Takakura

Vancomycin-resistant enterococci (VRE) have been detected from all over Japan since 1996. However, the incidence has been relatively low. In 2006, we organized Kyoto VRE surveillance group, established a VRE control program, and conducted an investigation which was to control the post-outbreak prevalence of VRE in the affected Kyoto region. The study period was from 2005 to 2010. Faecal samples were subjected to VRE screening, and vancomycin resistance genes were detected by polymerase chain reaction (PCR). A VRE control program consists of a laboratory-based faecal VRE screening system, annual surveillance of hospital inpatients and the promotion of adequate infection control measures. Number of VRE-detected patients was significantly smaller in hospitals with routine laboratory-based faecal VRE screening. From an- nual surveillance, the rate of faecal VRE carriage among the patients enrolled in the annual surveillance in- creased until 2007, when it reached 24(1.2%) of the 2,035 enrolled patients. The rate began to decrease in 2008 and, by 2010, reached a low of 4(0.17%) of the 2,408 enrolled patients. While VRE did spread within the Kyoto region, our program succeeded in controlling the overall VRE spread. [Review].

自1996年以来,在日本各地发现了耐万古霉素肠球菌(VRE)。然而,发病率一直相对较低。2006年,我们组织了京都VRE监测小组,制定了VRE控制规划,并开展了调查,以控制京都疫区爆发后VRE的流行情况。研究时间为2005年至2010年。对粪便样本进行VRE筛选,采用聚合酶链反应(PCR)检测万古霉素耐药基因。VRE控制规划包括以实验室为基础的粪便VRE筛查系统、对住院患者的年度监测和促进适当的感染控制措施。在以实验室为基础的常规粪便VRE筛查的医院中,VRE检出的患者数量明显较少。从年度监测来看,参加年度监测的患者中粪便VRE携带率上升至2007年,在2,035名入组患者中达到24例(1.2%)。这一比例从2008年开始下降,到2010年,在2408名入组患者中,这一比例降至4人(0.17%)的低点。虽然VRE确实在京都地区传播,但我们的项目成功地控制了VRE的总体传播。(审查)。
{"title":"[Vancomycin-Resistant Enterococci].","authors":"Shunji Takakura","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Vancomycin-resistant enterococci (VRE) have been detected from all over Japan since 1996. However, the incidence has been relatively low. In 2006, we organized Kyoto VRE surveillance group, established a VRE control program, and conducted an investigation which was to control the post-outbreak prevalence of VRE in the affected Kyoto region. The study period was from 2005 to 2010. Faecal samples were subjected to VRE screening, and vancomycin resistance genes were detected by polymerase chain reaction (PCR). A VRE control program consists of a laboratory-based faecal VRE screening system, annual surveillance of hospital inpatients and the promotion of adequate infection control measures. Number of VRE-detected patients was significantly smaller in hospitals with routine laboratory-based faecal VRE screening. From an- nual surveillance, the rate of faecal VRE carriage among the patients enrolled in the annual surveillance in- creased until 2007, when it reached 24(1.2%) of the 2,035 enrolled patients. The rate began to decrease in 2008 and, by 2010, reached a low of 4(0.17%) of the 2,408 enrolled patients. While VRE did spread within the Kyoto region, our program succeeded in controlling the overall VRE spread. [Review].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 11","pages":"1243-1248"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36909249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Importance of Clinical Laboratory and Molecular Epidemiology for Investigation of MRSA Outbreak]. 临床实验室和分子流行病学对MRSA疫情调查的重要性。
Keiji Kanemitsu, Kiwamu Nakamura

MRSA has been a major pathogen associated with nosocomial outbreaks. Moreover, the isolation of community-acquired MRSA(CA-MRSA) is increasing even in Japanese hospitals. It is necessary to carry out outbreak investigations in cooperation with the clinical laboratory as it is the site where MRSA is identi- fied. "Timing of information on MRSA from the clinical laboratory" is crucial for the ICT. To detect signs of an outbreak, information on the number of MRSA isolates is essential in every ward per week or month. It is desirable to perform active surveillance routinely. However, there are problems to be solved such as the cost of active surveillance, workload of laboratory technicians, and shortage of private rooms for isolation. It is necessary that the infection control department confirms clonal spread on analysis of the molecular epi- demiology, including the PCR-based open reading frame typing (POT) method. When the number of MRSA isolates increased and some strains had the same POT number on a ward, we suspected MRSA outbreak and strengthened infection control measures. We describe herein the importance of the relationship with the clinical laboratory for infection control and how to control an MRSA outbreak rapidly. [Review].

耐甲氧西林金黄色葡萄球菌是院内爆发的主要病原体。此外,即使在日本医院,社区获得性MRSA(CA-MRSA)的分离也在增加。有必要与临床实验室合作开展疫情调查,因为临床实验室是发现MRSA的场所。“从临床实验室获得MRSA信息的时机”对ICT至关重要。为了发现爆发的迹象,每周或每月每个病房的MRSA分离株数量信息是必不可少的。定期进行主动监视是可取的。然而,主动监测的成本、实验室技术人员的工作量以及隔离室的短缺等问题仍有待解决。感染控制部门有必要通过分子流行病学分析,包括基于pcr的开放阅读框分型(POT)方法,确认克隆传播。当某病房MRSA分离株数量增加且部分菌株具有相同的POT数时,我们怀疑发生了MRSA疫情,加强了感染控制措施。我们在此描述与临床实验室的关系的重要性感染控制和如何控制MRSA爆发迅速。(审查)。
{"title":"[Importance of Clinical Laboratory and Molecular Epidemiology for Investigation of MRSA Outbreak].","authors":"Keiji Kanemitsu,&nbsp;Kiwamu Nakamura","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>MRSA has been a major pathogen associated with nosocomial outbreaks. Moreover, the isolation of community-acquired MRSA(CA-MRSA) is increasing even in Japanese hospitals. It is necessary to carry out outbreak investigations in cooperation with the clinical laboratory as it is the site where MRSA is identi- fied. \"Timing of information on MRSA from the clinical laboratory\" is crucial for the ICT. To detect signs of an outbreak, information on the number of MRSA isolates is essential in every ward per week or month. It is desirable to perform active surveillance routinely. However, there are problems to be solved such as the cost of active surveillance, workload of laboratory technicians, and shortage of private rooms for isolation. It is necessary that the infection control department confirms clonal spread on analysis of the molecular epi- demiology, including the PCR-based open reading frame typing (POT) method. When the number of MRSA isolates increased and some strains had the same POT number on a ward, we suspected MRSA outbreak and strengthened infection control measures. We describe herein the importance of the relationship with the clinical laboratory for infection control and how to control an MRSA outbreak rapidly. [Review].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 11","pages":"1263-1270"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36909252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research Ethics on Handling of Clinical Samples]. 临床标本处理的研究伦理
Kaoru Tohyama

Medical research that has utilized the residual parts of clinical samples after routine laboratory examination has yielded numerous findings and contributed to the progress in clinical medicine as well as the detailed elucidation of pathological states of various diseases. However, ethics guidelines on human medical research have recently been established by the Japanese Government, and the Personal Information Protection Law has now imposed stricter rules. Therefore, the enactment of a new guideline became necessary for the secondary utilization of the residual parts of clinical samples. Basic concepts are proposed as follows: (1) research utilizing the residual parts of clinical samples can be performed using an opt-out form that guarantees the right to refuse'8eing enrolled in a study; and (2) the importance and significance of such studies using residual samples should be disseminated in society. To support the promotion of laboratory medical research and avoid the unnecessary or excessive suppres- sion of research, the Japanese Society of Laboratory Medicine is aiming to devise and disseminate appropriate ethics guidelines. [Review].

利用常规实验室检查后临床标本的残余部分进行的医学研究取得了许多成果,有助于临床医学的进步,也有助于详细阐明各种疾病的病理状态。然而,日本政府最近制定了关于人体医学研究的伦理准则,《个人信息保护法》现在也规定了更严格的规则。因此,制定新的指南对于临床样本残留部分的二次利用是必要的。提出的基本概念如下:(1)使用临床样本剩余部分的研究可以通过选择退出表格进行,以保证拒绝被纳入研究的权利;(2)残差样本研究的重要性和意义应该在社会上传播。为了支持促进实验室医学研究,避免不必要的或过度的对研究的压制,日本实验室医学学会的目标是制定和传播适当的伦理准则。(审查)。
{"title":"[Research Ethics on Handling of Clinical Samples].","authors":"Kaoru Tohyama","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Medical research that has utilized the residual parts of clinical samples after routine laboratory examination has yielded numerous findings and contributed to the progress in clinical medicine as well as the detailed elucidation of pathological states of various diseases. However, ethics guidelines on human medical research have recently been established by the Japanese Government, and the Personal Information Protection Law has now imposed stricter rules. Therefore, the enactment of a new guideline became necessary for the secondary utilization of the residual parts of clinical samples. Basic concepts are proposed as follows: (1) research utilizing the residual parts of clinical samples can be performed using an opt-out form that guarantees the right to refuse'8eing enrolled in a study; and (2) the importance and significance of such studies using residual samples should be disseminated in society. To support the promotion of laboratory medical research and avoid the unnecessary or excessive suppres- sion of research, the Japanese Society of Laboratory Medicine is aiming to devise and disseminate appropriate ethics guidelines. [Review].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 11","pages":"1290-1295"},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36909255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mitochondrial Dysfunction and Oligomer Formation in Neurodegenerative Diseases]. [神经退行性疾病的线粒体功能障碍和寡聚物形成]。
Ayako Okado-Matsumoto

Mitochondrial respiratory chain complexes are responsible for the oxidative phosphorylation system, and the association of these complexes is called a supercomplex. Since the formation of supercomplexes en- hances energy production and reduces electron leakage, the destabilization of supercomplexes may increase oxidative stress and mitochondrial dysfunction in the presence of aging and neurodegenerative disease. Both blue native polyacrylamide gel electrophoresis (BN-PAGE) and high-resolution clear native (hrCN) - PAGE are effective to examine supercomplex formation. Since the sensitivity of the in-gel enzyme activity assay of hrCN-PAGE is higher than that of BN-PAGE, we used hrCN-PAGE and two-dimensional hrCN/ SDS-PAGE to examine supercomplex formation in human mononuclear leukocytes, and compared them in relation to the sex and age group. We also applied the results to the analysis of soluble oligomer formation in neurodegenerative disease. Herein, we introduce the possibility of applying a clinical laboratory test for neurodegenerative diseases. [Review].

线粒体呼吸链复合物负责氧化磷酸化系统,这些复合物的结合被称为超复合物。由于超络合物的形成增强了能量产生并减少了电子泄漏,因此在衰老和神经退行性疾病的情况下,超络合物的不稳定可能会增加氧化应激和线粒体功能障碍。蓝色原生聚丙烯酰胺凝胶电泳(BN-PAGE)和高分辨率透明原生聚丙烯酰胺凝胶电泳(hrCN) -PAGE)都能有效检测超络合物的形成。由于hrCN- page凝胶内酶活性测定的敏感性高于BN-PAGE,我们使用hrCN- page和二维hrCN/ SDS-PAGE来检测人单核白细胞超复合物的形成,并比较它们与性别和年龄组的关系。我们还将结果应用于分析神经退行性疾病中可溶性低聚物的形成。在此,我们介绍应用神经退行性疾病的临床实验室测试的可能性。(审查)。
{"title":"[Mitochondrial Dysfunction and Oligomer Formation in Neurodegenerative Diseases].","authors":"Ayako Okado-Matsumoto","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Mitochondrial respiratory chain complexes are responsible for the oxidative phosphorylation system, and the association of these complexes is called a supercomplex. Since the formation of supercomplexes en- hances energy production and reduces electron leakage, the destabilization of supercomplexes may increase oxidative stress and mitochondrial dysfunction in the presence of aging and neurodegenerative disease. Both blue native polyacrylamide gel electrophoresis (BN-PAGE) and high-resolution clear native (hrCN) - PAGE are effective to examine supercomplex formation. Since the sensitivity of the in-gel enzyme activity assay of hrCN-PAGE is higher than that of BN-PAGE, we used hrCN-PAGE and two-dimensional hrCN/ SDS-PAGE to examine supercomplex formation in human mononuclear leukocytes, and compared them in relation to the sex and age group. We also applied the results to the analysis of soluble oligomer formation in neurodegenerative disease. Herein, we introduce the possibility of applying a clinical laboratory test for neurodegenerative diseases. [Review].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 10","pages":"1180-1186"},"PeriodicalIF":0.0,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36834208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[How to Interpret Data from Routine Laboratory Tests]. 【如何解释常规实验室检测数据】。
Go Matsumoto, Takayuki Honda

Routine laboratory tests are performed in almost all hospitals in the world. If you can fully interpret such routine laboratory tests, you can evaluate the general condition of patients in detail. In the reversed clinico- pathological conference (RCPC), we analyzed a patient's condition using only data from routine laboratory tests, as one of the most effective training methods to acquire the ability to interpret routine laboratory tests. In this RCPC, we discussed routine laboratory data from a patient who was transported by ambulance due to systemic weakness, and conducted interpretation of the data using the method of Shinshu University Hospital. At Shinshu University Hospital, we consider the time series results of the routine laboratory tests according to 13 steps, because our aim is to understand the patient's condition without oversight rather than to make a diagnosis. [Review].

世界上几乎所有医院都进行常规实验室检查。如果你能充分理解这些常规的实验室检查,你就可以详细地评估病人的一般情况。在反向临床病理会议(RCPC)中,我们仅使用常规实验室检查的数据来分析患者的病情,作为获得解释常规实验室检查能力的最有效培训方法之一。在这篇RCPC中,我们讨论了一位因全身虚弱而被救护车运送的患者的常规实验室数据,并使用信州大学医院的方法对数据进行了解释。在信州大学医院,我们根据13个步骤考虑常规实验室检查的时间序列结果,因为我们的目的是在没有监督的情况下了解患者的病情,而不是做出诊断。(审查)。
{"title":"[How to Interpret Data from Routine Laboratory Tests].","authors":"Go Matsumoto,&nbsp;Takayuki Honda","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Routine laboratory tests are performed in almost all hospitals in the world. If you can fully interpret such routine laboratory tests, you can evaluate the general condition of patients in detail. In the reversed clinico- pathological conference (RCPC), we analyzed a patient's condition using only data from routine laboratory tests, as one of the most effective training methods to acquire the ability to interpret routine laboratory tests. In this RCPC, we discussed routine laboratory data from a patient who was transported by ambulance due to systemic weakness, and conducted interpretation of the data using the method of Shinshu University Hospital. At Shinshu University Hospital, we consider the time series results of the routine laboratory tests according to 13 steps, because our aim is to understand the patient's condition without oversight rather than to make a diagnosis. [Review].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 10","pages":"1146-1152"},"PeriodicalIF":0.0,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36878301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Production of an Anti-PIVKA-II Recombinant Single-Chain-Antibody in Escherichia Coli]. [在大肠杆菌中制备抗pivka - ii重组单链抗体]。
Hiroyuki Satoh, Emiko Furukawa

Protein induced by vitamin K absence or antagonist-II (PIVKA-II) is an abnormal prothrombin lacking gamma-carboxylation of the 10 glutamic-acid residues in the N-terminal region. PIVKA-II has been used as an effective biomarker of hepatocellular carcinoma (HCC) since the PIVKA-II level is not correlated with that of alpha-fetoprotein (AFP), which is another effective biomarker for HCC. Monoclonal antibodies for the clinical biomarker test are usually expensive because of their high production costs. Recently, many studies involving the expression of the recombinant globulin molecules in bacterial cells and plants have been con- ducted. These studies have enabled us to produce recombinant monoclonal antibodies at much lower costs. In this study, we first produced a hybridoma expressing a monoclonal antibody against PIVKA-II, and then we constructed and produced a single-chain fragment-variable antibody (scFv), created by the linking of variable regions of light- and heavy-chains of the PIVKA-II monoclonal antibody with a peptide linker of triplicated GGGGS. The scFv was expressed in E. coli and exhibited high specificity for PIVYKA-II binding, while its binding titer was low. [Review].

由维生素K缺失或拮抗剂ii (PIVKA-II)诱导的蛋白是一种异常凝血酶原,在n端区域缺乏10个谷氨酸残基的γ -羧基化。PIVKA-II已被用作肝细胞癌(HCC)的有效生物标志物,因为PIVKA-II水平与甲胎蛋白(AFP)的水平无关,而甲胎蛋白是HCC的另一有效生物标志物。用于临床生物标志物检测的单克隆抗体由于其高昂的生产成本通常是昂贵的。近年来,人们对重组球蛋白分子在细菌细胞和植物中的表达进行了大量的研究。这些研究使我们能够以更低的成本生产重组单克隆抗体。在这项研究中,我们首先产生了一个表达PIVKA-II单克隆抗体的杂交瘤,然后我们构建并生产了一个单链片段可变抗体(scFv),该单链片段可变抗体是通过PIVKA-II单克隆抗体的轻链和重链可变区域与三倍GGGGS肽连接体连接而成的。scFv在大肠杆菌中表达,对PIVYKA-II具有较高的结合特异性,但其结合滴度较低。(审查)。
{"title":"[Production of an Anti-PIVKA-II Recombinant Single-Chain-Antibody in Escherichia Coli].","authors":"Hiroyuki Satoh,&nbsp;Emiko Furukawa","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Protein induced by vitamin K absence or antagonist-II (PIVKA-II) is an abnormal prothrombin lacking gamma-carboxylation of the 10 glutamic-acid residues in the N-terminal region. PIVKA-II has been used as an effective biomarker of hepatocellular carcinoma (HCC) since the PIVKA-II level is not correlated with that of alpha-fetoprotein (AFP), which is another effective biomarker for HCC. Monoclonal antibodies for the clinical biomarker test are usually expensive because of their high production costs. Recently, many studies involving the expression of the recombinant globulin molecules in bacterial cells and plants have been con- ducted. These studies have enabled us to produce recombinant monoclonal antibodies at much lower costs. In this study, we first produced a hybridoma expressing a monoclonal antibody against PIVKA-II, and then we constructed and produced a single-chain fragment-variable antibody (scFv), created by the linking of variable regions of light- and heavy-chains of the PIVKA-II monoclonal antibody with a peptide linker of triplicated GGGGS. The scFv was expressed in E. coli and exhibited high specificity for PIVYKA-II binding, while its binding titer was low. [Review].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 10","pages":"1187-1191"},"PeriodicalIF":0.0,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36834210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Reversed Clinicopathological Conference]. [逆转临床病理会议]。
Mitsutoshi Sugano, Takayuki Honda

Routine laboratory tests are the most frequently performed among clinical laboratory tests, and they can provide important information for the diagnosis and treatment of patients. They are more useful when sev- eral data are combined to interpret the pathophysiological state of a patient. Changes of routine laboratory data are important even when they are within their reference ranges, and they sometimes show a more de- tailed condition of the patient. In this RCPC, we-focused on changes of albumin and electrolytes, bacterial infections, and anemia. [Review].

常规实验室检查是临床实验室检查中最常见的一种,可为患者的诊断和治疗提供重要信息。当几种数据结合起来解释患者的病理生理状态时,它们更有用。常规实验室数据的变化是重要的,即使它们在其参考范围内,它们有时显示患者的更详细的情况。在本RCPC中,我们主要关注白蛋白和电解质的变化,细菌感染和贫血。(审查)。
{"title":"[Reversed Clinicopathological Conference].","authors":"Mitsutoshi Sugano,&nbsp;Takayuki Honda","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Routine laboratory tests are the most frequently performed among clinical laboratory tests, and they can provide important information for the diagnosis and treatment of patients. They are more useful when sev- eral data are combined to interpret the pathophysiological state of a patient. Changes of routine laboratory data are important even when they are within their reference ranges, and they sometimes show a more de- tailed condition of the patient. In this RCPC, we-focused on changes of albumin and electrolytes, bacterial infections, and anemia. [Review].</p>","PeriodicalId":21457,"journal":{"name":"Rinsho byori. The Japanese journal of clinical pathology","volume":"64 10","pages":"1193-1197"},"PeriodicalIF":0.0,"publicationDate":"2016-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36834211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rinsho byori. The Japanese journal of clinical pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1